UA110910C2 - Karboksamidni pyrazole derivatives as bruton tyrosine kinase inhibitors, pharmaceutical composition on the basis and method of treatment (options) - Google Patents
Karboksamidni pyrazole derivatives as bruton tyrosine kinase inhibitors, pharmaceutical composition on the basis and method of treatment (options)Info
- Publication number
- UA110910C2 UA110910C2 UAA201504267A UAA201504267A UA110910C2 UA 110910 C2 UA110910 C2 UA 110910C2 UA A201504267 A UAA201504267 A UA A201504267A UA A201504267 A UAA201504267 A UA A201504267A UA 110910 C2 UA110910 C2 UA 110910C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- tyrosine kinase
- karboksamidni
- options
- basis
- Prior art date
Links
Abstract
Даний документ описує сполуки,що утворюють ковалентні зв'язки з тирозинкіназою Брутона (ТКБ). Описані способи отримання таких сполук. Також описані фармацевтичні композиції, що містять такі сполуки. Описані способи використання інгібіторів ТКБ, самих по собі або в комбінації з іншими терапевтичними агентами, для лікування аутоімунних захворювань або станів, гетероімунних захворювань або станів, раку, включаючи лімфому, і запальних захворювань або станів.This document describes compounds that form covalent bonds with Bruton's tyrosine kinase (TKB). Methods for preparing such compounds are described. Also disclosed are pharmaceutical compositions containing such compounds. Described are the uses of TKB inhibitors, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261721920P | 2012-11-02 | 2012-11-02 | |
PCT/IB2013/059846 WO2014068527A1 (en) | 2012-11-02 | 2013-11-01 | Bruton's tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UA110910C2 true UA110910C2 (en) | 2016-02-25 |
Family
ID=55700669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201504267A UA110910C2 (en) | 2012-11-02 | 2013-01-11 | Karboksamidni pyrazole derivatives as bruton tyrosine kinase inhibitors, pharmaceutical composition on the basis and method of treatment (options) |
Country Status (2)
Country | Link |
---|---|
MA (1) | MA38056B1 (en) |
UA (1) | UA110910C2 (en) |
-
2013
- 2013-01-11 UA UAA201504267A patent/UA110910C2/en unknown
- 2013-11-01 MA MA38056A patent/MA38056B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA38056A1 (en) | 2018-01-31 |
MA38056B1 (en) | 2018-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015501067A1 (en) | Pyrrolopyrimidine compounds as kinase inhibitors | |
PH12015500940A1 (en) | Bruton`s tyrosine kinase inhibitors | |
PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
PH12014501815A1 (en) | Purinone compounds as kinase inhibitors | |
AU2018236800B2 (en) | DNA-PK inhibitors | |
MX2020010412A (en) | Inhibitors of bruton's tyrosine kinase. | |
NZ752526A (en) | Pyrrolobenzodiazepine conjugates | |
PH12018500284A1 (en) | 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
MX2017015574A (en) | Inhibitors of bruton's tyrosine kinase. | |
TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
NZ700928A (en) | Dna-pk inhibitors | |
MX2013011908A (en) | Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors. | |
SG10201902429PA (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
JO3366B1 (en) | Pyrazolyl Quinoxaline Kinase Inhibitors | |
MX2014000964A (en) | Substituted heterocyclic aza derivatives. | |
GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib | |
PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
UA110910C2 (en) | Karboksamidni pyrazole derivatives as bruton tyrosine kinase inhibitors, pharmaceutical composition on the basis and method of treatment (options) | |
EA201500446A1 (en) | PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL | |
TW201613926A (en) | Inhibitors of bruton's tyrosine kinase | |
MX369393B (en) | Phthalazine derivatives. | |
GB2519470A (en) | Bicyclic aza compounds as muscarinic M1 receptor agonists | |
MX2015015845A (en) | Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof. |